Rheumatoid Arthritis

Are We Playing It Safe?

Anja Strangfeld, MD, and Angela Zink, PhD | October 1, 2010

Tumor necrosis factor alpha inhibition and the risk of solid malignancies

Unique Meeting Accelerates RA Research

From the College | September 1, 2010

More than 50 rheumatoid arthritis (RA) investigators from across the U.S. recently met in Ft. Worth, Texas, to share information, present data and results from their innovative RA research projects, and brainstorm ways to work more closely together to find a cure for the disease.

REF’s Campaign to Support RA Research Nears its Initial Funding Target

Stanley B. Cohen, MD and E. William St.Clair, MD | September 1, 2010

The REF’s campaign to support RA research nears its initial funding target

The Key to Early Rheumatoid Arthritis

Annette H.M. van der Helm-van Mil, MD, PhD, and Tom W.J. Huizinga, MD, PhD | September 1, 2010

The conundrum of classification versus diagnosis

How to Provide Compassionate Care When Touch Is Painful

Iris Zink, RN, BSN, NP | August 1, 2010

Providing compassionate care when touch is painful

Research Offers Hope of New Therapies to Prevent Bone Loss and Destruction

From the College | August 1, 2010

A study recently published in Annals of the Rheumatic Diseases shows promise for potential new therapies to prevent bone loss and bone destruction in patients with rheumatoid arthritis (RA).

Our Commitment to Research

Stanley B. Cohen, MD | August 1, 2010

The ACR has a wide range of programs to support investigations in rheumatology

REF Investigators’ Meeting Brings Researchers Together to Search for RA Cure

Charlotte Huff | August 1, 2010

REF Investigators’ Meeting brings researchers together to search for RA cure

ACR and EULAR Debut New RA Classification Criteria in August

Gretchen Henkel | August 1, 2010

The complex development process focused on earlier detection and treatment

Within Our Reach: Collaborating to Find a Cure for RA

David R. Karp, MD, PhD | July 1, 2010

Research is critically important to find cures and accelerate patient care for the millions who suffer from arthritis and rheumatic disease. Despite its prevalence in the population and recent treatment advances, rheumatoid arthritis (RA) remains an incurable disease and receives disproportionately less research funding from federal sources than most other autoimmune diseases. This is precisely why the ACR Research and Education Foundation (REF) launched Within Our Reach: Finding a Cure for Rheumatoid Arthritis to directly invest in the types of innovative research not being done elsewhere in the country.